Medical and Pharmaceutical Revolution’s newly approved drug doubles pancreatic cancer survival time A 30-day course of Rasonque costs US$39,800 Rowan DunneAugust 31, 2026
Medical and Pharmaceutical Propanc Biopharma skyrockets from pancreatic cancer drug breakthrough Stock ascended by more than 150% Rowan DunneAugust 28, 2026
Mining Veteran analyst Michael Oliver doubles down on bullish precious metals outlook He expects that silver will have a 'furious' recovery this year and beyond Rowan DunneAugust 27, 2026
Mining Antimony mining activity continues heating up in Alaska The government has taken an interest in state players Felix Gold and Nova Minerals Rowan DunneAugust 27, 2026
Medical and Pharmaceutical Korean medtech operator Rayence launches portable ‘Anywhere’ X-ray Rayence's latest and greatest mobile devices feature a proprietary new de-noising feature Rowan DunneAugust 26, 2026
Mining Tungsten West sees 20% surge from US$97M mine revival investment The UK government has provided the capital because of its defence and aerospace needs Rowan DunneAugust 26, 2026
Medical and Pharmaceutical Artificial heart maker Picard soars from 39% revenue spike, narrowed net loss SynCardia's Total Artificial Heart serves as a temporary solution while patients wait for donors Rowan DunneAugust 24, 2026
AI and Autonomy Kazakhstan starts constructing first industrial-scale AI-robotics complex An initial investment of US$200 million has been procured Rowan DunneAugust 21, 2026
Medical and Pharmaceutical Craif raises US$33M to get its urine cancer test into American clinics Milestone follows the firm opening a California lab in April Rowan DunneAugust 20, 2026
Cannabis Aurora buys UK firms as it urges shareholders to reject Curaleaf takeover Britain's medical cannabis sector has been rapidly expanding Rowan DunneAugust 20, 2026